GenBody America

GenBody America is a small, five-employee company based in Mira Loma, California. The company specializes in the development and manufacturing of diagnostic tests. With over 20 years of combined experience in the diagnostic industry, GenBody leverages a strong network of partnerships with key institutes, universities, and hospitals. GenBody develops monoclonal antibodies and recombinant antigens in-house at their facility in South Korea. They offer a diverse range of diagnostic tests for over 78 human diseases. Notably, the company recently received US FDA Emergency Use Authorization for their COVID-19 Ag point-of-care antigen test for the detection of SARS-CoV-2 infection. This immunochromatographic rapid diagnostic test can be performed by healthcare professionals, with an at-home version currently under development. The company also secured a US National Institutes of Health contract for the US production of a visually read, single lateral flow rapid test system for SARS-CoV-2. A US factory in Jurupa Valley, California, is slated for completion in Q3 2021. GenBody is actively expanding its presence in the US market and anticipates significant growth in its regulatory, product development, and sales teams. For inquiries regarding job opportunities, please call 949-561-0664 or email [email protected]. For partnership opportunities, contact 949-561-0664 or [email protected].